The Predictive but Not Prognostic Value of MGMT Promoter Methylation Status in Elderly Glioblastoma Patients: A Meta-Analysis
Figure 4
outcome: OS; comparison: TMZ-containing therapies versus TMZ-free therapies: A. methylated tumors; B. unmethylated tumors.